NeoMedLight

📍 Villeurbanne, France🗓 Founded 2014👥 10 employees💰 Last funded Dec 2014
Medical Equipment Manufacturing🌐 neomedlight.com
Website LinkedIn
NeoMedLight develops innovative medical devices designed for phototherapy. The company owns a unique and exclusive technology: the emission of light through woven optical fibers: the Lightex®. NeoMedLight is committed to the treatment and prevention of oral mucositis and radiodermatitis, a huge unmet clinical need. Mucositis and radiodermatitis are the most common and debilitating side effects of chemotherapy and radiotherapy reported by cancer patients. CareMin650™ is an innovative solution leveraging our innovative Lightex® technology indicated for the prevention and treatment of mucositis and dermatitis in cancer patients. The CareMin650™ system allows patients to be treated safely, with precise control of treatment parameters and in a reproducible and consistent manner independent of the operator. The CareMin650™ is the latest innovation in Photobiomodulation for the treatment of cancer patients.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in NeoMedLight?
NeoMedLight has 1 investors on record on gritt.io, including 1 early-stage backers.
When did NeoMedLight last raise funding?
The most recent investment in NeoMedLight recorded on gritt.io was in December 2014.
When was NeoMedLight founded?
NeoMedLight was founded in 2014.
What industry is NeoMedLight in?
NeoMedLight operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is NeoMedLight based?
NeoMedLight is headquartered in Villeurbanne, France.